According to projections by the US Centers for Disease Control (CDC), there will be more deaths from antimicrobial-resistant bacteria than from all types of cancers combined by the year 2050. The problem of antibiotic resistance is such that the Organisation for Economic Co-operation and Development (OECD) projects the death of over 2.4 million people in Europe, North America and Australia from infections with resistant microorganisms in the next 30 years, at a healthcare cost of up to $3.5 billion (R61 billion) per year.

Nanocrystalline silver wound dressings are a potent first-line choice to help curb the danger of resistant bacteria and infection in the wound bed [Image: Shutterstock].

Please sign in to read more